All In MedTech

Device Trial Radar · NCT00756652

Mentor MemoryGel Post-Approval Study

MemoryGel Silicone Gel-Filled Breast Implant Post-Approval Study

Last checked: Nov 20, 2026Latest source record: Jun 4, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

42,491

Actual

Start

Nov 1, 2006

Primary completion

Jul 31, 2019

Study completion Jul 31, 2019

Sponsor

Lead sponsor
Mentor Worldwide, LLCNot on our public-company list
Sponsor type
Industry
First posted
Sep 22, 2008

More device trials from this sponsor

Design

Study type
Observational
Who can join
Female only, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

In November 2006, U.S. Food and Drug Administration (FDA) approved Mentor's MemoryGel silicone gel-filled breast implants for use in women who are undergoing primary or revisional breast augmentation and primary or revisional breast reconstruction surgery. This postapproval study is intended to satisfy one element of FDA's postapproval monitoring requirements. In January 2015, the FDA approved a protocol amendment that limits the scope of data collection for the study to the collection of only secondary procedure/reoperation data for MemoryGel participants.

Conditions

  • Breast Reconstruction
  • Breast Augmentation
  • Breast Revision

Interventions

  • Mentor Silicone Gel-Filled Breast ImplantsDevice

  • Saline Breast ImplantsDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Kaplan Meier Estimated Cumulative Incidence of Reported ComplicationsTime frame: 10 years
  2. Kaplan Meier Estimated Cumulative Incidence of ExplantationTime frame: 10 years

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.